Systematic genomic screen for tyrosine kinase muta...[Leukemia. 2008] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Leukemia. 2008 Oct;22(10):1966-9. Epub 2008 Aug 28. Links

Systematic genomic screen for tyrosine kinase mutations in CLL.

Brown JR, Levine RL, Thompson C, Basile G, Gilliland DG, Freedman AS.

PMID: 18754031 [PubMed - indexed for MEDLINE]

PMCID: PMC2704549

Related articles

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Leukemia. 2005 May; 19(5):750-8.

[Leukemia. 2005]
Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
Cancer. 2008 Mar 15; 112(6):1296-305.

[Cancer. 2008]
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
J Clin Oncol. 2006 Feb 20; 24(6):969-75. Epub 2006 Jan 17.

[J Clin Oncol. 2006]
ReviewChromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.
Pathol Oncol Res. 2005; 11(4):205-10. Epub 2005 Dec 31.

[Pathol Oncol Res. 2005]
ReviewThe B-cell receptor and ZAP-70 in chronic lymphocytic leukemia.
Best Pract Res Clin Haematol. 2007 Sep; 20(3):415-24.

[Best Pract Res Clin Haematol. 2007]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Systematic genomic screen for tyrosine kinase mutations in CLL.Systematic genomic screen for tyrosine kinase mutations in CLL.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show